Literature DB >> 8543309

Expression of the tissue metalloproteinase inhibitors TIMP-1 and TIMP-2 in malignant fibrous histiocytomas and dermatofibromas as studied by in situ hybridization and immunohistochemistry.

T Hurskainen1, Y Soini, A Tuuttila, M Höyhtyä, A Oikarinen, H Autio-Harmainen.   

Abstract

The expression of tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) was studied in eight malignant fibrous histiocytomas (MFH) and in eight dermatofibromas (DF) using in situ hybridization methods (ISH). Immunohistochemical stainings were also performed using corresponding antibodies to TIMP-1 and TIMP-2. In ISH the neoplastic cells of MFHs showed a high level of expression for both TIMP-1 and TIMP-2 mRNAs. The cells usually expressed similarly both TIMPs, except for osteoclast-like giant cells, which showed a distinct signal for TIMP-2 but not for TIMP-1. A distinctly lower level of both TIMP-1 and TIMP-2 mRNAs was seen in DFs. Immunohistochemical stainings were concordant with the results obtained by ISH. The findings suggest that the behavior of MFHs and DFs is not directly or solely dependent on the quantity of type IV collagenase inhibitors. The increased TIMP synthesis in MFHs might represent a chaotic response of malignant cells to increased matrix degradation. Alternatively, it may reflect a deranged communication between type IV collagenases and TIMPs in malignant tissues.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8543309     DOI: 10.1016/s0046-8177(96)90136-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  2 in total

1.  Role of matrix metalloproteinase (MMP) 2 and MMP-9 in soft tissue sarcoma.

Authors:  Hyun Kee Yang; Kwang Cheul Jeong; Yang Kyung Kim; Sung Taek Jung
Journal:  Clin Orthop Surg       Date:  2014-11-10

2.  Malignant Fibrous Histiocytoma, Aggressive Fibromatosis and Benign Fibrous Tumors Express mRNA for the Metalloproteinase Inducer EMMPRIN and the Metalloproteinases MMP-2 and MT1-MMP.

Authors:  J Ahlén; U Enberg; C Larsson; O Larsson; T Frisk; O Brosjö; A Rosen; M Bäckdahl
Journal:  Sarcoma       Date:  2001
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.